Management system standard
Medical device quality management
ISO 13485
Read ISO 13485:2016 alongside FDA QMSR, outsourced processes, lifecycle controls and the distinction between certification and legal compliance.
Read the referenceComparative study
A publication can change while a legal reference remains fixed. FDA device quality rules, Coast Guard electrical references and U.S. dangerous-goods regulations illustrate why an edition decision needs more than a publisher’s current catalogue.
A standards publisher releases a new edition, and a procurement team changes its approved-document list. If an existing legal requirement identifies the earlier edition, has that update improved compliance or created a second baseline? The question is especially important when the same supplier serves regulated markets and customers with different contractual specifications.
This study examines why publication, legal adoption and implementation are separate events. Its practical aim is to make an edition decision explainable: which document applies, to which activity, on what authority, and from what date? An older year is not sufficient evidence that a regulatory reference is obsolete, and a new publication is not itself evidence of legal adoption.
The sources are three U.S. regulatory examples and the federal incorporation framework. Section 820.7 identifies ISO 13485:2016 and the specified ISO 9000:2015 terminology material used in QMSR. Section 110.10-1 lists particular Coast Guard electrical references and their uses. Section 171.7 identifies dangerous-goods reference material, including the seventh revised UN Manual of Tests and Criteria and its first amendment.
The study does not evaluate every later publisher edition or claim technical equivalence between editions. It asks what the public legal records establish about the reference mechanism. Product-specific transition provisions and exceptions remain part of the final applicability assessment.
The comparison separates four dates: publication of a technical document, legal adoption of the identified edition, the legal instrument's effective date, and any applicable compliance or transition date. A fifth date records when the reviewer checked the sources. None is used as a substitute for another.
For each example, the identified document is read with the adopting provision and the scope to which the reference applies. FDA's specific explanation of future ISO revisions is checked against that framework. The analysis does not treat authorized access to an incorporated standard as permission to reproduce it, nor use a publisher's catalogue status to rewrite the regulation.
Scroll horizontally to view all columns.
| Example | What the checked record identifies | What a new publication does not establish | Decision record |
|---|---|---|---|
| Device QMSR | Specified ISO material in 820.7 | That a later ISO edition has replaced the adopted text | Regulation, adopted edition and FDA additions |
| Future ISO changes | FDA will assess revisions and use rulemaking where appropriate, according to its FAQ | Automatic federal amendment on publication | Later legal action and its scope |
| Marine electrical references | Named editions and applicable uses in 110.10-1 | Acceptance of a whole series or every later edition | Part, edition and receiving provision |
| Dangerous-goods references | Listed publications in 171.7 | That the newest UN download governs every U.S. shipment | Adopted material plus the operative shipping rule |
These examples share a controlled legal reference. Their technical subjects and transition mechanisms remain different.
The first finding is that edition control has at least two legitimate baselines: the technical document selected for the work and the document legally invoked for the activity. They may coincide, but the coincidence must be demonstrated. A register that stores only one current-year value can erase the legal baseline.
The second finding is that a series-level statement conceals important detail. The Coast Guard's reference list connects individual documents with receiving provisions. Describing this as acceptance of all IEC marine standards would discard both the specified editions and their limited applications.
The third finding concerns update authority. FDA's explanation makes future revision a regulatory evaluation question, not a publisher-triggered substitution. This supports a controlled comparison: identify changes, assess their relevance, and preserve the adopted requirements until an applicable legal action or authorized route changes the conclusion.
An edition-change review should produce a decision for each affected use. Start with the product configuration and destination market, locate the adopting provision, and record the exact edition and amendments. Then identify contracts, certification schemes or laboratory instructions that may invoke different material.
An illustrative device manufacturer might assess a newer technical publication for internal improvement while retaining the QMSR baseline in its regulatory matrix. Its decision record should explain which procedures changed, why the changes are compatible with the applicable requirements, and what evidence demonstrates implementation. This is different from asserting that a new certificate has changed federal law.
For suppliers, communicate the controlled reference and acceptance evidence in the purchase specification. Where an alternate edition is proposed, require an explicit evaluation and approval route. Preserve the original report and the change assessment together. Editing the year on an old report would neither perform the new tests nor establish that the supplied configuration has been reassessed.
The study does not conclude that every legal reference is permanently fixed. Some instruments provide transition options, authorize alternatives or use other mechanisms. The actual provision must be read before classifying the reference.
It also does not decide whether a particular old test result remains usable. That depends on the product, date, unchanged configuration, legal continuity conditions and purpose for which the evidence is offered. A publisher's withdrawal can be relevant to technical review without independently terminating every legal use. Conversely, retaining an old legally adopted edition does not justify ignoring a newly identified product hazard or another applicable requirement.
The listed references were checked as legal or agency records, with the editions and receiving provisions read in context. The comparison does not reproduce ISO or IEC clauses. FDA's FAQ is used only for its regulatory explanation. The UN Manual is identified through the U.S. incorporation list here; a separate battery study examines publication and transport evidence together.
Sources checked: 19 October 2026. Published: 19 October 2026.
Continue with the medical-device quality reference for the incorporated QMSR context and the quality-management reference for document-control responsibilities. Use the Source Version Register to preserve parallel publication and adoption records. The U.S. QMSR profile provides the related federal pathway. Record an actual change decision before replacing an edition in operating instructions.
Medical device quality management · Quality management systems · All studies.
Source record
Sources checked 2026-10-19. This date records preparation of this resource; publication, legal and transition dates are identified separately.
specific FDA incorporated editions
21 CFR 820.7: Incorporation by reference www.ecfr.goveffect of future ISO revisions
FDA QMSR Frequently Asked Questions www.fda.govedition-specific maritime references
46 CFR 110.10-1: Incorporation by reference www.ecfr.govdangerous-goods incorporated publications
49 CFR 171.7: Reference material www.ecfr.govgeneral adoption and amendment framework
1 CFR Part 51: Incorporation by Reference www.ecfr.gov